Biotechnology: Global Industry Guide

Home >
Life Sciences >
Biotechnology >
Biotechnology: Global Industry Guide

Report price : $ 1 495
Publication date : October 2009

The Biotechnology: Global Industry Guide is an essential resource for top-level data and analysis covering the Biotechnology industry. It includes detailed data on market size and segmentation, textual analysis of the key trends and competitive landscape, and profiles of the leading companies. This incisive report provides expert analysis on a global, regional and country basis.

Scope of the Report

* Contains an executive summary and data on value, volume and segmentation

* Provides textual analysis of the industry's prospects, competitive landscape and profiles of the leading companies

* Incorporates in-depth five forces competitive environment analysis and scorecards

* Covers the Global, European and Asia-Pacific markets as well as individual chapters on 5 major markets (France, Germany, Japan, the UK and the US).

* Includes a five-year forecast of the industry

Highlights

The global biotechnology market grew by 8.8% in 2008 to reach a value of $216.3 billion.

In 2013, the global biotechnology market is forecast to have a value of $305.7 billion, an increase of 41.3% since 2008.

The medical/healthcare segment proved the most lucrative for the global biotechnology market in 2008, generating 69% of the market's overall revenues.

Americas leads the global biotechnology market accounting for 57.9% of the market's revenue.

Why you should buy this report

* Spot future trends and developments

* Inform your business decisions

* Add weight to presentations and marketing materials

* Save time carrying out entry-level research

Market Definition

The biotechnology market consists of the development, manufacturing and marketing of products based on advanced biotechnology research. The market value reflects revenues of companies within this industry from product sales, licensing fees, royalties and research funding.

TABLE OF CONTENTS
CHAPTER 1 INTRODUCTION 23
1.1 What is this report about? 23
1.2 Who is the target reader? 23
1.3 How to use this report 23
1.4 Definitions 23
CHAPTER 2 GLOBAL BIOTECHNOLOGY 24
2.1 Market Overview 24
2.2 Market Value 25
2.3 Market Segmentation I 26
2.4 Market Segmentation II 27
2.5 Five Forces Analysis 28
2.6 Market Forecasts 34
CHAPTER 3 BIOTECHNOLOGY IN ASIA-PACIFIC 35
3.1 Market Overview 35
3.2 Market Value 36
3.3 Market Segmentation I 37
3.4 Market Segmentation II 38
3.5 Five Forces Analysis 39
3.6 Market Forecasts 45
CHAPTER 4 BIOTECHNOLOGY IN EUROPE 46
4.1 Market Overview 46
4.2 Market Value 47
4.3 Market Segmentation I 48
4.4 Market Segmentation II 49
4.5 Five Forces Analysis 50
4.6 Market Forecasts 56
4.7 Macroeconomic Indicators 57
CHAPTER 5 BIOTECHNOLOGY IN BELGIUM 58
5.1 Market Overview 58
5.2 Market Value 59
5.3 Market Segmentation I 60
5.4 Market Segmentation II 61
5.5 Five Forces Analysis 62
5.6 Market Forecasts 68
5.7 Macroeconomic Indicators 69
CHAPTER 6 BIOTECHNOLOGY IN CANADA 71
6.1 Market Overview 71
6.2 Market Value 72
6.3 Market Segmentation I 73
6.4 Market Segmentation II 74
6.5 Five Forces Analysis 75
6.6 Market Forecasts 81
6.7 Macroeconomic Indicators 82
CHAPTER 7 BIOTECHNOLOGY IN CHINA 84
7.1 Market Overview 84
7.2 Market Value 85
7.3 Market Segmentation I 86
7.4 Market Segmentation II 87
7.5 Five Forces Analysis 88
7.6 Market Forecasts 94
7.7 Macroeconomic Indicators 95
CHAPTER 8 BIOTECHNOLOGY IN FRANCE 97
8.1 Market Overview 97
8.2 Market Value 98
8.3 Market Segmentation I 99
8.4 Market Segmentation II 100
8.5 Five Forces Analysis 101
8.6 Market Forecasts 107
8.7 Macroeconomic Indicators 108
CHAPTER 9 BIOTECHNOLOGY IN GERMANY 110
9.1 Market Overview 110
9.2 Market Value 111
9.3 Market Segmentation I 112
9.4 Market Segmentation II 113
9.5 Five Forces Analysis 114
9.6 Market Forecasts 120
9.7 Macroeconomic Indicators 121
CHAPTER 10 BIOTECHNOLOGY IN ITALY 123
10.1 Market Overview 123
10.2 Market Value 124
10.3 Market Segmentation I 125
10.4 Market Segmentation II 126
10.5 Five Forces Analysis 127
10.6 Market Forecasts 133
10.7 Macroeconomic Indicators 134
CHAPTER 11 BIOTECHNOLOGY IN JAPAN 136
11.1 Market Overview 136
11.2 Market Value 137
11.3 Market Segmentation I 138
11.4 Market Segmentation II 139
11.5 Five Forces Analysis 140
11.6 Market Forecasts 146
11.7 Macroeconomic Indicators 147
CHAPTER 12 BIOTECHNOLOGY IN THE NETHERLANDS 149
12.1 Market Overview 149
12.2 Market Value 150
12.3 Market Segmentation I 151
12.4 Market Segmentation II 152
12.5 Five Forces Analysis 153
12.6 Market Forecasts 159
12.7 Macroeconomic Indicators 160
CHAPTER 13 BIOTECHNOLOGY IN SPAIN 162
13.1 Market Overview 162
13.2 Market Value 163
13.3 Market Segmentation I 164
13.4 Market Segmentation II 165
13.5 Five Forces Analysis 166
13.6 Market Forecasts 172
13.7 Macroeconomic Indicators 173
CHAPTER 14 BIOTECHNOLOGY IN THE UNITED KINGDOM 175
14.1 Market Overview 175
14.2 Market Value 176
14.3 Market Segmentation I 177
14.4 Market Segmentation II 178
14.5 Five Forces Analysis 179
14.6 Market Forecasts 185
14.7 Macroeconomic Indicators 186
CHAPTER 15 BIOTECHNOLOGY IN THE UNITED STATES 188
15.1 Market Overview 188
15.2 Market Value 189
15.3 Market Segmentation I 190
15.4 Market Segmentation II 191
15.5 Five Forces Analysis 192
15.6 Market Forecasts 198
15.7 Macroeconomic Indicators 199
CHAPTER 16 COMPANY PROFILES 200
16.1 Leading Companies 200
CHAPTER 17 APPENDIX 211
17.1 Data Research Methodology 211

LIST OF TABLES
Table 1: Global Biotechnology Market Value: $ billion, 2004-2008 25
Table 2: Global Biotechnology Market Segmentation I: % Share, by Value, 2008 26
Table 3: Global Biotechnology Market Segmentation II: % Share, by Value, 2008 27
Table 4: Global Biotechnology Market Value Forecast: $ billion, 2008-2013 34
Table 5: Asia-Pacific Biotechnology Market Value: $ billion, 2004-2008 36
Table 6: Asia-Pacific Biotechnology Market Segmentation I: % Share, by Value, 2008 37
Table 7: Asia-Pacific Biotechnology Market Segmentation II: % Share, by Value, 2008 38
Table 8: Asia-Pacific Biotechnology Market Value Forecast: $ billion, 2008-2013 45
Table 9: Europe Biotechnology Market Value: $ billion, 2004-2008 47
Table 10: Europe Biotechnology Market Segmentation I: % Share, by Value, 2008 48
Table 11: Europe Biotechnology Market Segmentation II: % Share, by Value, 2008 49
Table 12: Europe Biotechnology Market Value Forecast: $ billion, 2008-2013 56
Table 13: Europe Exchange Rate, 2004-2008 57
Table 14: Belgium Biotechnology Market Value: $ billion, 2004-2008 59
Table 15: Belgium Biotechnology Market Segmentation I: % Share, by Value, 2008 60
Table 16: Belgium Biotechnology Market Segmentation II: % Share, by Value, 2008 61
Table 17: Belgium Biotechnology Market Value Forecast: $ billion, 2008-2013 68
Table 18: Belgium Size of Population (million) , 2004-2008 69
Table 19: Belgium GDP (Constant 2000 Prices, $ billion), 2004-2008 69
Table 20: Belgium Inflation, 2004-2008 70
Table 21: Belgium Exchange Rate, 2004-2008 70
Table 22: Canada Biotechnology Market Value: $ billion, 2004-2008 72
Table 23: Canada Biotechnology Market Segmentation I: % Share, by Value, 2008 73
Table 24: Canada Biotechnology Market Segmentation II: % Share, by Value, 2008 74
Table 25: Canada Biotechnology Market Value Forecast: $ billion, 2008-2013 81
Table 26: Canada Size of Population (million) , 2004-2008 82
Table 27: Canada GDP (Constant 2000 Prices, $ billion), 2004-2008 82
Table 28: Canada Inflation, 2004-2008 83
Table 29: Canada Exchange Rate, 2004-2008 83
Table 30: China Biotechnology Market Value: $ billion, 2004-2008 85
Table 31: China Biotechnology Market Segmentation I: % Share, by Value, 2008 86
Table 32: China Biotechnology Market Segmentation II: % Share, by Value, 2008 87
Table 33: China Biotechnology Market Value Forecast: $ billion, 2008-2013 94
Table 34: China Size of Population (million) , 2004-2008 95
Table 35: China GDP (Constant 2000 Prices, $ billion), 2004-2008 95
Table 36: China Inflation, 2004-2008 96
Table 37: China Exchange Rate, 2004-2008 96
Table 38: France Biotechnology Market Value: $ billion, 2004-2008 98
Table 39: France Biotechnology Market Segmentation I: % Share, by Value, 2008 99
Table 40: France Biotechnology Market Segmentation II: % Share, by Value, 2008 100
Table 41: France Biotechnology Market Value Forecast: $ billion, 2008-2013 107
Table 42: France Size of Population (million) , 2004-2008 108
Table 43: France GDP (Constant 2000 Prices, $ billion), 2004-2008 108
Table 44: France Inflation, 2004-2008 109
Table 45: France Exchange Rate, 2004-2008 109
Table 46: Germany Biotechnology Market Value: $ billion, 2004-2008 111
Table 47: Germany Biotechnology Market Segmentation I: % Share, by Value, 2008 112
Table 48: Germany Biotechnology Market Segmentation II: % Share, by Value, 2008 113
Table 49: Germany Biotechnology Market Value Forecast: $ billion, 2008-2013 120
Table 50: Germany Size of Population (million) , 2004-2008 121
Table 51: Germany GDP (Constant 2000 Prices, $ billion), 2004-2008 121
Table 52: Germany Inflation, 2004-2008 122
Table 53: Germany Exchange Rate, 2004-2008 122
Table 54: Italy Biotechnology Market Value: $ billion, 2004-2008 124
Table 55: Italy Biotechnology Market Segmentation I: % Share, by Value, 2008 125
Table 56: Italy Biotechnology Market Segmentation II: % Share, by Value, 2008 126
Table 57: Italy Biotechnology Market Value Forecast: $ billion, 2008-2013 133
Table 58: Italy Size of Population (million) , 2004-2008 134
Table 59: Italy GDP (Constant 2000 Prices, $ billion), 2004-2008 134
Table 60: Italy Inflation, 2004-2008 135
Table 61: Italy Exchange Rate, 2004-2008 135
Table 62: Japan Biotechnology Market Value: $ billion, 2004-2008 137
Table 63: Japan Biotechnology Market Segmentation I: % Share, by Value, 2008 138
Table 64: Japan Biotechnology Market Segmentation II: % Share, by Value, 2008 139
Table 65: Japan Biotechnology Market Value Forecast: $ billion, 2008-2013 146
Table 66: Japan Size of Population (million) , 2004-2008 147
Table 67: Japan GDP (Constant 2000 Prices, $ billion), 2004-2008 147
Table 68: Japan Inflation, 2004-2008 148
Table 69: Japan Exchange Rate, 2004-2008 148
Table 70: Netherlands Biotechnology Market Value: $ million, 2004-2008 150
Table 71: Netherlands Biotechnology Market Segmentation I: % Share, by Value, 2008 151
Table 72: Netherlands Biotechnology Market Segmentation II: % Share, by Value, 2008 152
Table 73: Netherlands Biotechnology Market Value Forecast: $ million, 2008-2013 159
Table 74: Netherlands Size of Population (million) , 2004-2008 160
Table 75: Netherlands GDP (Constant 2000 Prices, $ billion), 2004-2008 160
Table 76: Netherlands Inflation, 2004-2008 161
Table 77: Netherlands Exchange Rate, 2004-2008 161
Table 78: Spain Biotechnology Market Value: $ billion, 2004-2008 163
Table 79: Spain Biotechnology Market Segmentation I: % Share, by Value, 2008 164
Table 80: Spain Biotechnology Market Segmentation II: % Share, by Value, 2008 165
Table 81: Spain Biotechnology Market Value Forecast: $ billion, 2008-2013 172
Table 82: Spain Size of Population (million) , 2004-2008 173
Table 83: Spain GDP (Constant 2000 Prices, $ billion), 2004-2008 173
Table 84: Spain Inflation, 2004-2008 174
Table 85: Spain Exchange Rate, 2004-2008 174
Table 86: United Kingdom Biotechnology Market Value: $ billion, 2004-2008 176
Table 87: United Kingdom Biotechnology Market Segmentation I: % Share, by Value, 2008 177
Table 88: United Kingdom Biotechnology Market Segmentation II: % Share, by Value, 2008 178
Table 89: United Kingdom Biotechnology Market Value Forecast: $ billion, 2008-2013 185
Table 90: United Kingdom Size of Population (million) , 2004-2008 186
Table 91: United Kingdom GDP (Constant 2000 Prices, $ billion), 2004-2008 186
Table 92: United Kingdom Inflation, 2004-2008 187
Table 93: United Kingdom Exchange Rate, 2004-2008 187
Table 94: United States Biotechnology Market Value: $ billion, 2004-2008 189
Table 95: United States Biotechnology Market Segmentation I: % Share, by Value, 2008 190
Table 96: United States Biotechnology Market Segmentation II: % Share, by Value, 2008 191
Table 97: United States Biotechnology Market Value Forecast: $ billion, 2008-2013 198
Table 98: United States Size of Population (million) , 2004-2008 199
Table 99: United States GDP (Constant 2000 Prices, $ billion), 2004-2008 199
Table 100: United States Inflation, 2004-2008 199
Table 101: Key Facts: Amgen Inc. 200
Table 102: Key Financials: Amgen Inc. 201
Table 103: Key Facts: Genentech, Inc. 202
Table 104: Key Financials: Genentech, Inc. 203
Table 105: Key Facts: Biogen Idec, Inc. 205
Table 106: Key Financials: Biogen Idec, Inc. 207
Table 107: Key Facts: UCB Group 208
Table 108: Key Financials: UCB Group 209

LIST OF FIGURES
Figure 1: Global Biotechnology Market Value: $ billion, 2004-2008 25
Figure 2: Global Biotechnology Market Segmentation I: % Share, by Value, 2008 26
Figure 3: Global Biotechnology Market Segmentation II: % Share, by Value, 2008 27
Figure 4: Forces Driving Competition in the Global Biotechnology Market, 2008 28
Figure 5: Drivers of Buyer Power in the Global Biotechnology Market, 2008 29
Figure 6: Drivers of Supplier Power in the Global Biotechnology Market, 2008 30
Figure 7: Factors Influencing the Likelihood of New Entrants in the Global Biotechnology Market, 2008 31
Figure 8: Factors Influencing the Threat of Substitutes in the Global Biotechnology Market, 2008 32
Figure 9: Drivers of Degree of Rivalry in the Global Biotechnology Market, 2008 33
Figure 10: Global Biotechnology Market Value Forecast: $ billion, 2008-2013 34
Figure 11: Asia-Pacific Biotechnology Market Value: $ billion, 2004-2008 36
Figure 12: Asia-Pacific Biotechnology Market Segmentation I: % Share, by Value, 2008 37
Figure 13: Asia-Pacific Biotechnology Market Segmentation II: % Share, by Value, 2008 38
Figure 14: Forces Driving Competition in the Biotechnology Market in Asia-Pacific, 2008 39
Figure 15: Drivers of Buyer Power in the Biotechnology Market in Asia-Pacific, 2008 40
Figure 16: Drivers of Supplier Power in the Biotechnology Market in Asia-Pacific, 2008 41
Figure 17: Factors Influencing the Likelihood of New Entrants in the Biotechnology Market in Asia-Pacific, 2008 42
Figure 18: Factors Influencing the Threat of Substitutes in the Biotechnology Market in Asia-Pacific, 2008 43
Figure 19: Drivers of Degree of Rivalry in the Biotechnology Market in Asia-Pacific, 2008 44
Figure 20: Asia-Pacific Biotechnology Market Value Forecast: $ billion, 2008-2013 45
Figure 21: Europe Biotechnology Market Value: $ billion, 2004-2008 47
Figure 22: Europe Biotechnology Market Segmentation I: % Share, by Value, 2008 48
Figure 23: Europe Biotechnology Market Segmentation II: % Share, by Value, 2008 49
Figure 24: Forces Driving Competition in the Biotechnology Market in Europe, 2008 50
Figure 25: Drivers of Buyer Power in the Biotechnology Market in Europe, 2008 51
Figure 26: Drivers of Supplier Power in the Biotechnology Market in Europe, 2008 52
Figure 27: Factors Influencing the Likelihood of New Entrants in the Biotechnology Market in Europe, 2008 53
Figure 28: Factors Influencing the Threat of Substitutes in the Biotechnology Market in Europe, 2008 54
Figure 29: Drivers of Degree of Rivalry in the Biotechnology Market in Europe, 2008 55
Figure 30: Europe Biotechnology Market Value Forecast: $ billion, 2008-2013 56
Figure 31: Belgium Biotechnology Market Value: $ billion, 2004-2008 59
Figure 32: Belgium Biotechnology Market Segmentation I: % Share, by Value, 2008 60
Figure 33: Belgium Biotechnology Market Segmentation II: % Share, by Value, 2008 61
Figure 34: Forces Driving Competition in the Biotechnology Market in Belgium, 2008 62
Figure 35: Drivers of Buyer Power in the Biotechnology Market in Belgium, 2008 63
Figure 36: Drivers of Supplier Power in the Biotechnology Market in Belgium, 2008 64
Figure 37: Factors Influencing the Likelihood of New Entrants in the Biotechnology Market in Belgium, 2008 65
Figure 38: Factors Influencing the Threat of Substitutes in the Biotechnology Market in Belgium, 2008 66
Figure 39: Drivers of Degree of Rivalry in the Biotechnology Market in Belgium, 2008 67
Figure 40: Belgium Biotechnology Market Value Forecast: $ billion, 2008-2013 68
Figure 41: Canada Biotechnology Market Value: $ billion, 2004-2008 72
Figure 42: Canada Biotechnology Market Segmentation I: % Share, by Value, 2008 73
Figure 43: Canada Biotechnology Market Segmentation II: % Share, by Value, 2008 74
Figure 44: Forces Driving Competition in the Biotechnology Market in Canada, 2008 75
Figure 45: Drivers of Buyer Power in the Biotechnology Market in Canada, 2008 76
Figure 46: Drivers of Supplier Power in the Biotechnology Market in Canada, 2008 77
Figure 47: Factors Influencing the Likelihood of New Entrants in the Biotechnology Market in Canada, 2008 78
Figure 48: Factors Influencing the Threat of Substitutes in the Biotechnology Market in Canada, 2008 79
Figure 49: Drivers of Degree of Rivalry in the Biotechnology Market in Canada, 2008 80
Figure 50: Canada Biotechnology Market Value Forecast: $ billion, 2008-2013 81
Figure 51: China Biotechnology Market Value: $ billion, 2004-2008 85
Figure 52: China Biotechnology Market Segmentation I: % Share, by Value, 2008 86
Figure 53: China Biotechnology Market Segmentation II: % Share, by Value, 2008 87
Figure 54: Forces Driving Competition in the Biotechnology Market in China, 2008 88
Figure 55: Drivers of Buyer Power in the Biotechnology Market in China, 2008 89
Figure 56: Drivers of Supplier Power in the Biotechnology Market in China, 2008 90
Figure 57: Factors Influencing the Likelihood of New Entrants in the Biotechnology Market in China, 2008 91
Figure 58: Factors Influencing the Threat of Substitutes in the Biotechnology Market in China, 2008 92
Figure 59: Drivers of Degree of Rivalry in the Biotechnology Market in China, 2008 93
Figure 60: China Biotechnology Market Value Forecast: $ billion, 2008-2013 94
Figure 61: France Biotechnology Market Value: $ billion, 2004-2008 98
Figure 62: France Biotechnology Market Segmentation I: % Share, by Value, 2008 99
Figure 63: France Biotechnology Market Segmentation II: % Share, by Value, 2008 100
Figure 64: Forces Driving Competition in the Biotechnology Market in France, 2008 101
Figure 65: Drivers of Buyer Power in the Biotechnology Market in France, 2008 102
Figure 66: Drivers of Supplier Power in the Biotechnology Market in France, 2008 103
Figure 67: Factors Influencing the Likelihood of New Entrants in the Biotechnology Market in France, 2008 104
Figure 68: Factors Influencing the Threat of Substitutes in the Biotechnology Market in France, 2008 105
Figure 69: Drivers of Degree of Rivalry in the Biotechnology Market in France, 2008 106
Figure 70: France Biotechnology Market Value Forecast: $ billion, 2008-2013 107
Figure 71: Germany Biotechnology Market Value: $ billion, 2004-2008 111
Figure 72: Germany Biotechnology Market Segmentation I: % Share, by Value, 2008 112
Figure 73: Germany Biotechnology Market Segmentation II: % Share, by Value, 2008 113
Figure 74: Forces Driving Competition in the Biotechnology Market in Germany, 2008 114
Figure 75: Drivers of Buyer Power in the Biotechnology Market in Germany, 2008 115
Figure 76: Drivers of Supplier Power in the Biotechnology Market in Germany, 2008 116
Figure 77: Factors Influencing the Likelihood of New Entrants in the Biotechnology Market in Germany, 2008 117
Figure 78: Factors Influencing the Threat of Substitutes in the Biotechnology Market in Germany, 2008 118
Figure 79: Drivers of Degree of Rivalry in the Biotechnology Market in Germany, 2008 119
Figure 80: Germany Biotechnology Market Value Forecast: $ billion, 2008-2013 120
Figure 81: Italy Biotechnology Market Value: $ billion, 2004-2008 124
Figure 82: Italy Biotechnology Market Segmentation I: % Share, by Value, 2008 125
Figure 83: Italy Biotechnology Market Segmentation II: % Share, by Value, 2008 126
Figure 84: Forces Driving Competition in the Biotechnology Market in Italy, 2008 127
Figure 85: Drivers of Buyer Power in the Biotechnology Market in Italy, 2008 128
Figure 86: Drivers of Supplier Power in the Biotechnology Market in Italy, 2008 129
Figure 87: Factors Influencing the Likelihood of New Entrants in the Biotechnology Market in Italy, 2008 130
Figure 88: Factors Influencing the Threat of Substitutes in the Biotechnology Market in Italy, 2008 131
Figure 89: Drivers of Degree of Rivalry in the Biotechnology Market in Italy, 2008 132
Figure 90: Italy Biotechnology Market Value Forecast: $ billion, 2008-2013 133
Figure 91: Japan Biotechnology Market Value: $ billion, 2004-2008 137
Figure 92: Japan Biotechnology Market Segmentation I: % Share, by Value, 2008 138
Figure 93: Japan Biotechnology Market Segmentation II: % Share, by Value, 2008 139
Figure 94: Forces Driving Competition in the Biotechnology Market in Japan, 2008 140
Figure 95: Drivers of Buyer Power in the Biotechnology Market in Japan, 2008 141
Figure 96: Drivers of Supplier Power in the Biotechnology Market in Japan, 2008 142
Figure 97: Factors Influencing the Likelihood of New Entrants in the Biotechnology Market in Japan, 2008 143
Figure 98: Factors Influencing the Threat of Substitutes in the Biotechnology Market in Japan, 2008 144
Figure 99: Drivers of Degree of Rivalry in the Biotechnology Market in Japan, 2008 145
Figure 100: Japan Biotechnology Market Value Forecast: $ billion, 2008-2013 146
Figure 101: Netherlands Biotechnology Market Value: $ million, 2004-2008 150
Figure 102: Netherlands Biotechnology Market Segmentation I: % Share, by Value, 2008 151
Figure 103: Netherlands Biotechnology Market Segmentation II: % Share, by Value, 2008 152
Figure 104: Forces Driving Competition in the Biotechnology Market in the Netherlands, 2008 153
Figure 105: Drivers of Buyer Power in the Biotechnology Market in the Netherlands, 2008 154
Figure 106: Drivers of Supplier Power in the Biotechnology Market in the Netherlands, 2008 155
Figure 107: Factors Influencing the Likelihood of New Entrants in the Biotechnology Market in the Netherlands, 2008 156
Figure 108: Factors Influencing the Threat of Substitutes in the Biotechnology Market in the Netherlands, 2008 157
Figure 109: Drivers of Degree of Rivalry in the Biotechnology Market in the Netherlands, 2008 158
Figure 110: Netherlands Biotechnology Market Value Forecast: $ million, 2008-2013 159
Figure 111: Spain Biotechnology Market Value: $ billion, 2004-2008 163
Figure 112: Spain Biotechnology Market Segmentation I: % Share, by Value, 2008 164
Figure 113: Spain Biotechnology Market Segmentation II: % Share, by Value, 2008 165
Figure 114: Forces Driving Competition in the Biotechnology Market in Spain, 2008 166
Figure 115: Drivers of Buyer Power in the Biotechnology Market in Spain, 2008 167
Figure 116: Drivers of Supplier Power in the Biotechnology Market in Spain, 2008 168
Figure 117: Factors Influencing the Likelihood of New Entrants in the Biotechnology Market in Spain, 2008 169
Figure 118: Factors Influencing the Threat of Substitutes in the Biotechnology Market in Spain, 2008 170
Figure 119: Drivers of Degree of Rivalry in the Biotechnology Market in Spain, 2008 171
Figure 120: Spain Biotechnology Market Value Forecast: $ billion, 2008-2013 172
Figure 121: United Kingdom Biotechnology Market Value: $ billion, 2004-2008 176
Figure 122: United Kingdom Biotechnology Market Segmentation I: % Share, by Value, 2008 177
Figure 123: United Kingdom Biotechnology Market Segmentation II: % Share, by Value, 2008 178
Figure 124: Forces Driving Competition in the Biotechnology Market in the United Kingdom, 2008 179
Figure 125: Drivers of Buyer Power in the Biotechnology Market in the United Kingdom, 2008 180
Figure 126: Drivers of Supplier Power in the Biotechnology Market in the United Kingdom, 2008 181
Figure 127: Factors Influencing the Likelihood of New Entrants in the Biotechnology Market in the United Kingdom, 2008 182
Figure 128: Factors Influencing the Threat of Substitutes in the Biotechnology Market in the United Kingdom, 2008 183
Figure 129: Drivers of Degree of Rivalry in the Biotechnology Market in the United Kingdom, 2008 184
Figure 130: United Kingdom Biotechnology Market Value Forecast: $ billion, 2008-2013 185
Figure 131: United States Biotechnology Market Value: $ billion, 2004-2008 189
Figure 132: United States Biotechnology Market Segmentation I: % Share, by Value, 2008 190
Figure 133: United States Biotechnology Market Segmentation II: % Share, by Value, 2008 191
Figure 134: Forces Driving Competition in the Biotechnology Market in the United States, 2008 192
Figure 135: Drivers of Buyer Power in the Biotechnology Market in the United States, 2008 193
Figure 136: Drivers of Supplier Power in the Biotechnology Market in the United States, 2008 194
Figure 137: Factors Influencing the Likelihood of New Entrants in the Biotechnology Market in the United States, 2008 195
Figure 138: Factors Influencing the Threat of Substitutes in the Biotechnology Market in the United States, 2008 196
Figure 139: Drivers of Degree of Rivalry in the Biotechnology Market in the United States, 2008 197
Figure 140: United States Biotechnology Market Value Forecast: $ billion, 2008-2013 198
Figure 141: Revenues & Profitability: Amgen Inc. 201
Figure 142: Revenues & Profitability: Genentech, Inc. 204
Figure 143: Revenues & Profitability: Biogen Idec, Inc. 207
Figure 144: Revenues & Profitability: UCB Group 210

RELATED REPORTS

Biotechnology in Australia - Industry Risk Rating Report

$ 788
October 2009

INDUSTRY RISK RATINGS REPORTThis is the replacement for August 2009 edition of Biotechnology in Australia Industry Risk Ratings Report.Industry Risk Ratings SynopsisThis Industry Risk Ratings report evaluates the inherent risks associated with the Biotechnology in Australia industry. Industry Risk ...

Industries : Biotechnology

Biotechnology in the US - Industry Risk Rating Report

$ 803
October 2009

INDUSTRY RISK RATINGS REPORTThis is the replacement for March 2009 edition of Biotechnology in the US Industry Risk Ratings Report.Industry Risk Ratings SynopsisThis Industry Risk Ratings report evaluates the inherent risks associated with the Biotechnology in the US industry. Industry Risk is ass ...

Industries : Biotechnology

Novo Nordisk A/S - SWOT Analysis

$ 125
September 2009

Datamonitor's Novo Nordisk A/S - SWOT Analysis company profile is the essential source for top-level company data and information. Novo Nordisk A/S - SWOT Analysis examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue l ...

Industries : Biotechnology

Global Top 10 Biotechnology Companies — Industry, Financial and SWOT Analysis

$ 1 895
July 2009

Scope:‘Top 10 Global Biotechnology Companies Report: Strategic evaluation of industry and key players’ is a business report that provides a comprehensive view of the global biotechnology industry and its top 10 companies.The report includes the following:– Industry analysis including market va ...

Industries : Biotechnology

Competitor Analysis: VEGF and VEGF-R Agonists and Antagonists

$ 750
September 2009

Product description The present Competitive Intelligence Report about VEGF and VEGF-R agonists and antagonists provides a competitor evaluation in the field of VEGF and its receptor targeting molecules for treatment of cancer, AMD and for neuroprotection as of September 2009. Purchase of the down ...

Industries : Biotechnology, Pharmaceutical

Biotech in Autoimmune and Inflammatory Disease 2006, 2nd Edition

$ 2 999
May 2006

Despite their diversity, global healthcare systems are increasingly converging in the need and desire to contain costs of healthcare, and especially those associated with pharmaceuticals. At the same time, Big Pharma are having to contend with a dearth of invention, patent expirations, and increased ...

Industries : Biotechnology

Global Stem Cell and Advanced Technologies Market

$ 4 650
November 2009

Report DescriptionThe stem cell market is growing rapidly due to increasing regulatory approval and public acceptance bodies. The benefits of stem cell therapy are attracting an increasing number of patients. The product submarket for human and embryo stem cells are expected to drive the growth of t ...

Industries : Biotechnology, Pharmaceutical

4SC AG - Company Report

$ 750
September 2009

Private Company Reports provide up to date insight into the structure and operations of privately-held pharmaceutical, biotechnology and biomedical companies.Scope of the report:Accessing accurate, current and comprehensive content on private companies can be challenging and Life Science Analytics h ...

Industries : Biotechnology, Pharmaceutical

7TM Pharma A/S - Company Report

$ 750
September 2009

Industries : Biotechnology, Pharmaceutical

A.N.B. Laboratories Co., Ltd. - Company Report

$ 750
September 2009

Industries : Biotechnology, Pharmaceutical

Biotechnology: Global Industry Guide - get our PDF brochure

24/7 Customer Service

Contact Shadi now !

(866) 682 9815
Ask Shadi by email

Related industries

Biotechnology Industry

ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.